Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in mice

Scott E Williams1, Idoia Garcia2, Andrew J Crowther3

  • 1Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA scott_williams@med.unc.edu gershont@neurology.unc.edu.

Development (Cambridge, England)
|October 10, 2015
PubMed

Insights

ASPM gene mutations cause microcephaly by increasing neural progenitor cell death. ASPM also drives pediatric brain tumor growth, suggesting it

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Oncology

Background:

  • Gene mutations affecting brain size are linked to microcephaly and brain tumors.
  • ASPM is a gene implicated in familial microcephaly.
  • Medulloblastoma is the most common malignant pediatric brain tumor.

Purpose of the Study:

  • To investigate the role of ASPM in cerebellar neurogenesis and medulloblastoma.
  • To understand how ASPM mutations impact brain development and tumor growth.

Main Methods:

  • Genetic deletion of ASPM in mouse models.
  • Analysis of cerebellar granule neuron progenitors (CGNPs) and medulloblastoma.
  • Assessing mitotic progression, DNA damage, and apoptosis.

Main Results:

  • ASPM deletion in mice reduced cerebellar growth but paradoxically increased CGNP mitotic rate.
  • ASPM deficiency led to impaired mitosis, altered cell division, and increased DNA damage in CGNPs, causing apoptosis.
  • Deleting ASPM in medulloblastoma models reduced tumor growth and increased DNA damage.

Conclusions:

  • ASPM regulates mitosis and mitigates DNA damage during neural progenitor cell division.
  • ASPM mutations cause microcephaly via progenitor apoptosis.
  • ASPM sustains medulloblastoma growth.

Related Concept Videos